Trevarx Biomedical announced it raised $500,000 in an initial filing from an offering of $500,000

Company

Location

About

Trevarx Biomedical is a mission-driven company focused on curing breast, ovarian, and prostate cancer through innovative small molecule radiopharmaceuticals. Backed by a team of experts and a distinguished scientific advisory board, Trevarx brings deep experience in scientific research, regulatory strategy, multi-center trials, and GMP manufacturing. The company is well positioned to rapidly advance its unique theranostic solution, offering integrated trial expertise and support to accelerate the commercialization of cutting-edge radiopharmaceutical technologies.